Clinical Outcomes of Primary Adenosquamous Carcinoma of the Lung Treated by Surgery

Yang Haitang,Yao Feng,Sun Yifeng,Yu Keke,Gu Haiyong,Chen Tianxiang,Zhao Heng
DOI: https://doi.org/10.3877/cma.j.issn.2095-8773.2015.03.005
2015-01-01
Abstract:Objective To analyze the clinicopathological characteristics and prognostic factors associated with primary adenosquamous carcinoma (ASC) of the lung. Methods The clinical data of patients with ASC of the lung confirmed by postoperative pathology between October 2008 and December 2014 in Shanghai Chest Hospital were retrospectively analyzed. The 3-year overall survival, 5-year overall survival and 5-year disease-free survival of patients was analyzed, and the prognostic factors for overall survival and disease-free survival were explored by univariate analysis and multivariate analysis. Results A total of 205 patients were identified, including 145 (70.7%) males and 60(9.3%) females with an average age of (60.7±9.7) years (range 21-70 years). There were significant differences in the prognosis among patients with N0, N1 and N2(N0 vs N1, P=0.031; N1 vs N2, P=0.037) and among patients with Ⅰ, Ⅱ and ⅢA(Ⅰ vs Ⅱ, P=0.021; Ⅱ vs ⅢA, P=0.007). Cox multivariate analysis demonstrated that T stage of tumor(P=0.011), TNM stage (P<0.001) and adjuvant chemotherapy(P=0.008) were independent prognostic factors for overall survival, and TNM stage (P<0.001) and adjuvant chemotherapy(P=0.005) were independent prognostic factors for disease-free survival. Conclusions The prognosis of ASC is associated with T stage and TNM stage, and postoperative adjuvant chemotherapy can increase the survival of patients with ASC. Key words: Adenosquamous carcinoma; Surgery; Survival
What problem does this paper attempt to address?